Resources
Explore our library of capabilities
Targeted Protein Degradation
We are glad to show you the overview of Axcelead’s platform for molecular glue degrader…
We would like to introduce one of our strengths, high-throughput synthesis technology for bifunctional degrader….
Axcelead’s design-make-test-analysis cycle for bifunctional degrader allows rapid discovery promising compounds. The capability to design…
Axcelead is capable of offering one-stop solution for molecular glue degraders and bifunctional degrader drug…
1 Minute Guide for HTS Platform
At Axcelead, we’re dedicated to developing selective kinase inhibitors using our kinase panel assay. With…
Properly assessing kinase selectivity is crucial in developing protein kinase inhibitor drugs. However, using comprehensive…
At Axcelead, we recognize the importance of HTS follow-up activities in successful drug discovery. Our…
Phenotypic drug discovery is a valuable approach to finding drugs with functional effects in disease…
Global Webinar
Safety-related drug attrition is still a major hurdle in the development of innovative pharmaceuticals. Therefore,…
Axcelead is the first integrated drug discovery solutions provider in the pharmaceutical industry in Japan,…
Drug discovery and development is a challenging and long process. It takes more than 10…
How to identify and validate potential drug targets when looking into treatments for a specific…
Hot Topics
CEO, Yoshi asked Dr. Fumihiro Jinno, who is head of pharmacokinetics testing for IND, about…
Axcelead is the first integrated drug discovery solutions provider in the pharmaceutical industry in Japan,…
Screening Capabilities
Phenotypic screening is a powerful approach to find novel hit / lead compounds and novel…
Mass spectrometry (MS) has been increasingly used for high throughput screening (HTS) because of its…
High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug…